CD4 and lung carcinoma: Our experiment confirmed that, within the same age group, the proportion of CD4+CD25+FOXP3+/CD4+ T cells and the expression level of FOXP3 mRNA in the peripheral blood were significantly higher in lung cancer patients than in healthy controls.